Albany Molecular Research, Inc. (AMRI): Bristol-Myers Squibb Company Stops Development of Depression Drug

Published: Aug 14, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Albany Molecular Research Inc. fell the most in three months after saying that Bristol-Myers Squibb Co. ended development of a depression drug under partnership. Albany Molecular declined 10 percent to $11.31 at the close in New York, the biggest single-day drop since May 7. Shares of the Albany, New York-based company have more than doubled this year.

Help employers find you! Check out all the jobs and post your resume.

Back to news